Vnitr Lek 2010, 56(4):320-323

Percutaneous coronary interventions in diabetic patients

J. ©»ásek
I. interní klinika Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Jan Vojáček, DrSc., FESC, FACC

Diabetes mellitus (DM) is a serious medical problem. The patients with diabetes have higher risk of coronary artery diseases. Diabetes mellitus also increases the risk of complication resulting from revascularization treatment in compare with non-diabetic patients. The first studies, which compare the surgical and percutaneous revascularization proved, that the major difference between these two revascularization techniques is in patients with diabetes. The difference is inflected by necessity of repeated revascularization after PCI, which is caused by higher incidence of a restenosis in patients with DM. Mortality, myocardial infarction and stroke are more frequent in diabetic patients, but the difference between PCI and surgical treated groups is not significant. Though the restenosis had significantly decreased due to of drug-eluted stents, the surgical revascularization is preferred method of treatment in patients with insulin-dependent diabetes, poorly compensated diabetes and patients with multiple complex coronary disease.

Keywords: diabetes mellitus; percutaneous coronary revascularisation; aorto-coronary bypass; stent; drug-eluted stent

Received: February 7, 2010; Published: April 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©»ásek J. Percutaneous coronary interventions in diabetic patients. Vnitr Lek. 2010;56(4):320-323.
Download citation

References

  1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497. Go to original source... Go to PubMed...
  2. Haffner SM, Lehto S, Rönnemaa T et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234. Go to original source... Go to PubMed...
  3. Malmberg K, Yusuf S, Gerstein HC et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000; 102: 1014-1019. Go to original source... Go to PubMed...
  4. Yusuf S, Zucker D, Peduzzi P et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344: 563-570. Go to original source... Go to PubMed...
  5. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med 1996; 335: 217-225.
  6. Serruys PW, Unger F, Sousa LF et al. Arterial Revascularization Therapies Study Group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001; 344: 1117-1124. Go to original source... Go to PubMed...
  7. Abizaid A, Costa MA, Centemero M et al. Arterial Revascularization Therapy Study Group. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 2001; 104: 533-538. Go to original source... Go to PubMed...
  8. Serruys PW, Ong AT, van Herwerden LA et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005; 46: 575-581. Go to original source...
  9. Daemen J, Boersma E, Flather M et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 2008; 118: 1146-1154. Go to original source... Go to PubMed...
  10. Moreno PR, Murcia AM, Palacios IF et al. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation 2000; 102: 2180-2184. Go to original source... Go to PubMed...
  11. Ehtisham M. Meta-analysis of DES in diabetic data. EuroPCR 2007.
  12. Stenestrand U, James SK, Lindbäck J et al. SCAAR/SWEDEHEART study group. Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J 2010; 31: 177-186. Go to original source... Go to PubMed...
  13. Serruys PW, Lemos PA, van Hout BA. Arterial Revascularisation Therapies Study part II Steering Committee and Investigators. Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II). Heart 2004; 90: 995-998. Go to original source... Go to PubMed...
  14. Serruys PW, Morice MC, Kappetein AP et al. SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-972. Go to original source... Go to PubMed...
  15. Serruys PW, Onuma Y, Garg S et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention 2009; 5: 50-56. Go to original source... Go to PubMed...
  16. Javaid A, Steinberg DH, Buch AN et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 2007; 116 (Suppl 11): 1200-1206. Go to original source... Go to PubMed...
  17. Qiao Y, Ma C, Nie S et al. Twelve months clinical outcome of drug-eluting stents implantation or coronary artery bypass surgery for the treatment of diabetic patients with multivessel disease. Clin Cardiol 2009; 32: E24-E30. Go to original source... Go to PubMed...
  18. Stone GW, Midei M, Newman W et al. SPIRIT III Investigators. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Circulation 2009; 119: 680-686. Go to original source... Go to PubMed...
  19. Stone GW. SPIRIT IV: Xience V trumps Taxus for clinicly driven end points, although diabetic questions linger. San Francisco, TCT Conference 2009.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.